Publication

Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Sheila Angeles-Han, Emory UniversityChristina F. Pelajo, Emory UniversityLarry Vogler, Emory UniversityKelly Rouster Stevens, Childrens Healthcare AtlantaChristine Kennedy, Childrens Healthcare AtlantaLori Ponder, Emory UniversityCourtney McCracken, Emory UniversityJorge Lopez-Benitez, Emory UniversityCarolyn Drews-Botsch, Emory UniversitySampath Prahalad
Language
  • English
Date
  • 2013-12-01
Publisher
  • Journal of Rheumatology
Publication Version
Copyright Statement
  • The Journal of Rheumatology Copyright © 2013. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0315-162X
Volume
  • 40
Issue
  • 12
Start Page
  • 2088
End Page
  • 2096
Grant/Funding Information
  • Dr. Prahalad is supported by The National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR060893), The Marcus Foundation Inc. and The Arthritis Foundation.
  • Dr. Angeles-Han was supported by Award Number K23EY021760 from the National Eye Institute and also by a grant from the American College of Rheumatology Research and Education Foundation and the Arthritis Foundation Career Development Bridge Funding Award.
  • The work was done with the support of NIH funding through CARRA.
Abstract
  • Objective: To characterize the epidemiology and clinical course of children with juvenile idiopathic arthritis-associated uveitis (JIA-U) in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry and explore differences between African American (AA) and non-Hispanic white (NHW) children. Methods: There were 4983 children with JIA enrolled in the CARRA Registry. Of those, 3967 NHW and AA children were included in this study. Demographic and disease-related data were collected from diagnosis to enrollment. Children with JIA were compared to those with JIA-U. Children with JIA-U were also compared by race. Results: There were 459/3967 children (11.6%) with JIA-U in our cohort with a mean age (SD) of 11.4 years (± 4.5) at enrollment. Compared to children with JIA, they were younger at arthritis onset, more likely to be female, had < 5 joints involved, had oligoarticular JIA, and were antinuclear antibody (ANA)-positive, rheumatoid factor (RF)-negative, and anticitrullinated protein antibody-negative. Predictors of uveitis development included female sex, early age of arthritis onset, and oligoarticular JIA. Polyarticular RF-positive JIA subtype was protective. Nearly 3% of children with JIA-U were AA. However, of the 220 AA children with JIA, 6% had uveitis; in contrast, 12% of the 3721 NHW children with JIA had uveitis. Conclusion: In the CARRA registry, the prevalence of JIA-U in AA and NHW children is 11.6%. We confirmed known uveitis risk markers (ANA positivity, younger age at arthritis onset, and oligoarticular JIA). We describe a decreased likelihood of uveitis in AA children and recommend further exploration of race as a risk factor in a larger population of AA children.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items